Standout Papers

Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial 2023 2026 202462
  1. Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial (2023)
    Hamdi Jama, Michael Nakai et al. Nature Cardiovascular Research

Immediate Impact

23 standout
Sub-graph 1 of 10

Citing Papers

Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder
2024 Standout
Immune and inflammatory mechanisms in hypertension
2024 Standout
2 intermediate papers

Works of Michael Nakai being referenced

Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial
2023 Standout
The Gut Microbiome of Heart Failure With Preserved Ejection Fraction
2021

Author Peers

Author Last Decade Papers Cites
Michael Nakai 201 230 82 16 336
Hendrik Bartolomaeus 119 173 56 17 323
Marta Gawryś-Kopczyńska 200 264 69 12 392
Abigail G. Casso 160 191 60 19 405
Klaudia Bielińska 177 227 67 7 336
Nicole S. Litwin 107 169 73 16 312
Nikhil Kumar 130 190 29 12 377
Maksymilian Onyszkiewicz 163 206 55 14 319
M.J. Martínez-Ramírez 154 187 47 24 405
Xuefang Yan 135 235 33 8 374
Muhammad Umar Cheema 106 181 39 11 319

All Works

Loading papers...

Rankless by CCL
2026